What is KPV? KPV is a short-chain tripeptide derived from alpha-MSH. It is highly regarded in clinical research for its targeted, multi-faceted approach to reducing inflammation and combating microbial threats without suppressing the immune system.
Key Research & Benefits:
-
Targeted Inflammation Control: Actively modulates pro-inflammatory cytokines, making it a leading candidate for managing autoimmune and inflammatory conditions.
-
Gut Health & IBD Support: Demonstrates significant safety and efficacy in the treatment of inflammatory bowel disease (IBD) across various delivery methods.
-
Advanced Wound Healing: Studies indicate KPV accelerates the tissue repair process while actively reducing localized infections.
-
Scar Minimization: Shows strong potential in reducing fibrotic tissue buildup and minimizing scarring following surgery or trauma.
